GMP cell banking services
uBriGene provides GMP cell banking services for secure, compliant storage of iPSC, viral vector, and microbial cell banks.
ubrigene.comCrawled Nov 21, 2026
uBriGene provides GMP cell banking services for secure, compliant storage of iPSC, viral vector, and microbial cell banks.
uBriGene develops analytical assays for in-depth QC testing of CGT products to ensure quality and regulatory compliance.
uBriGene provides proven CDMO services for AAV, LVV, RNA-LNP, in vivo CAR-T, iPSC, cell therapy, plasmids, and GMP manufacturing.
uBriGene’s CRO services help achieve preclinical success in cell and gene therapy from tech transfer to scalable production.
uBriGene offers reliable viral vector manufacturing for AAV, lentivirus, and adenovirus production in CGT applications.
The page outlines challenges and strategies for scalable manufacturing, quality, and regulatory success in AAV commercialization.
The page covers essential analytical methods and testing to ensure iPSC quality, safety, potency, and regulatory compliance.
uBriGene supports ATMP success through scalable manufacturing, analytical development, and regulatory expertise.
The page compares circRNA’s advantages, challenges, and potential against mRNA in next-generation RNA therapeutics.
The page describes circRNA therapy’s benefits, challenges, and manufacturing strategies for next-generation RNA therapeutics.
The page details quality control strategies for ensuring the safety, identity, potency, and consistency of iPSC-derived therapies.
uBriGene Biosciences Inc. closes 150 million CNY (20 million USD) Series C+ round
uBriGene Biosciences completes several hundred million yuan Series C round funding
uBriGene (Boston) Biosciences completed the transaction with Mustang Bio, Inc. (Nasdaq: MBIO)
The page highlights uBriGene’s latest ATMP breakthroughs, platform advances, partnerships, scientific presentations, and industry events.
Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition
uBriGene offers career opportunities in cell and gene therapy manufacturing and development.
uBriGene provides custom quotes for CRO/CDMO services in plasmids, viral vectors, RNA-LNP, and cell therapy.
uBriGene offers special deals on premium CRO/CDMO solutions and plasmid, viral vector, iPSC, and gene editing products.
The page introduces uBriGene’s leadership team, which advances innovation in cell and gene therapy manufacturing and translational development.
uBriGene bridges ATMP innovation and commercialization through GMP quality and client-focused solutions.
uBriGene operates state-of-the-art GMP facilities for plasmid, viral vector, RNA-LNP, and cell therapy manufacturing.
uBriGene ensures global regulatory compliance, GMP quality systems, and robust QC for ATMP manufacturing.
Cell & Gene Therapy CDMO for AAV, LVV, in vivo CAR-T, iPSC, plasmid, RNA-LNP, CAR-T and other Cell products. GMP production, analytics & QC